Speaker Profile
Ph.D., Partner, Astellas
Biography
Christopher H. Woelk, PhD, is an External Innovation Partner in Oncology at Astellas Pharma, where he identifies and evaluates innovative therapeutic platforms, emerging technologies, and opportunities for scientific collaboration. His expertise spans computational biology, multi-omics, artificial intelligence, and translational drug discovery.
Previously, Dr. Woelk served as Head of Translational Genomics at Verge Genomics and Head of Systems Biology at Merck's Exploratory Science Center. He also held academic research positions at the University of Southampton and University of California, San Diego. He earned his PhD from the University of Oxford and has authored more than 80 peer-reviewed publications. His work focuses on translating computational and biological insights into new therapeutic discoveries.
Talk
AI for Clinical Decision Support Systems Showcase:
Immunosis
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
